Table 5.
Odds ratio associated with risk factors for medical history-ascertained T2D complications and comorbidity in sub-Saharan Africa.
| Complication/comorbidity | Risk factor | uORa | 95% CI | P-value | aORb | 95% CI | P-value | aORc | 95% CI | P-value |
|---|---|---|---|---|---|---|---|---|---|---|
| Diabetic coma | Age (Years) | 1.02 | (1.01–1.03) | 0.004 | 1.01 | (1.00–1.02) | 0.161 | 1.01 | (1.00–1.03) | 0.100 |
| Sex (Ref = males) | 0.84 | (0.63–1.12) | 0.246 | 0.95 | (0.70–1.30) | 0.756 | 1.00 | (0.72–1.38) | 0.983 | |
| BMI (Kg/m2) | 0.96 | (0.93–0.99) | 0.004 | 0.96 | (0.93–0.99) | 0.005 | 0.96 | (0.93–0.99) | 0.008 | |
| Duration of T2D | 1.05 | (1.03–1.07) | <0.001 | 1.04 | (1.02–1.06) | <0.001 | 1.04 | (1.02–1.07) | <0.001 | |
| Accra, Ghana | 1.25 | (0.88–1.78) | 0.218 | 2.05 | (1.17–3.59) | 0.012 | 2.10 | (1.19–3.68) | 0.010 | |
| Kumasi, Ghana | 0.69 | (0.41–1.16) | 0.160 | 1.13 | (0.57–2.22) | 0.731 | 1.13 | (0.54–2.37) | 0.748 | |
| Enugu, Nigeria | 1.19 | (0.81–1.76) | 0.375 | 1.66 | (0.93–2.96) | 0.086 | 1.67 | (0.93–3.00) | 0.084 | |
| Ibadan, Nigeria | 1.30 | (0.97–1.74) | 0.080 | 1.85 | (1.12–3.05) | 0.016 | 1.79 | (1.08–2.97) | 0.025 | |
| Lagos, Nigeria | 0.61 | (0.34–1.12) | 0.110 | 0.92 | (0.44–1.91) | 0.815 | 0.97 | (0.46–2.03) | 0.937 | |
| Visual problems | Age (Years) | 1.00 | (1.00–1.01) | 0.195 | 1.01 | (1.00–1.02) | 0.002 | 1.02 | (1.01–1.03) | <0.001 |
| Sex (Ref = males) | 0.95 | (0.81–1.11) | 0.537 | 0.98 | (0.82–1.17) | 0.82 | 0.99 | (0.82–1.19) | 0.889 | |
| BMI (Kg/m2) | 0.95 | (0.94–0.97) | <0.001 | 0.97 | (0.95–0.98) | <0.001 | 0.97 | (0.95–0.98) | <0.001 | |
| Duration of T2D | 1.03 | (1.02–1.04) | <0.001 | 1.03 | (1.02–1.04) | <0.001 | 1.03 | (1.01–1.04) | <0.001 | |
| Accra, Ghana | 1.34 | (1.10–1.65) | 0.004 | 1.63 | (1.23–2.17) | 0.001 | 1.65 | (1.24–2.21) | 0.001 | |
| Kumasi, Ghana | 3.02 | (2.30–3.98) | <0.001 | 3.19 | (2.27–4.47) | <0.001 | 3.64 | (2.49–5.31) | <0.001 | |
| Enugu, Nigeria | 2.79 | (2.20–3.53) | <0.001 | 2.58 | (1.91–3.49) | <0.001 | 2.62 | (1.93–3.56) | <0.001 | |
| Ibadan, Nigeria | 0.51 | (0.27–0.38) | <0.001 | 0.51 | (0.40–0.66) | <0.001 | 0.43 | (0.33–0.56) | <0.001 | |
| Lagos, Nigeria | 0.87 | (0.66–1.13) | 0.295 | 0.92 | (0.661.28) | 0.622 | 0.91 | (0.65–1.29) | 0.609 | |
| Non-healing ulcers | Age (Years) | 1.00 | (0.98–1.01) | 0.742 | 1.00 | (0.98–1.01) | 0.603 | 1.00 | (0.98–1.02) | 0.775 |
| Sex (Ref = males) | 0.71 | (0.50–1.00) | 0.052 | 0.64 | (0.43–0.93) | 0.020 | 0.57 | (0.38–0.87) | 0.009 | |
| BMI (Kg/m2) | 0.97 | (0.94–1.01) | 0.102 | 0.99 | (0.96–1.03) | 0.730 | 1.01 | (0.97–1.05) | 0.763 | |
| Duration of T2D | 1.02 | (1.00–1.05) | 0.044 | 1.03 | (1.00–1.06) | 0.027 | 1.02 | (1.00–1.05) | 0.098 | |
| Accra, Ghana | 1.17 | (0.75–1.81) | 0.494 | 2.10 | (1.00–4.37) | 0.049 | 2.05 | (0.98–4.29) | 0.058 | |
| Kumasi, Ghana | 2.52 | (1.63–3.88) | 0.000 | 4.17 | (2.01–8.63) | <0.001 | 4.70 | (2.20–10.06) | <0.001 | |
| Enugu, Nigeria | 1.11 | (0.68–1.80) | 0.688 | 1.90 | (0.90–4.04) | 0.100 | 1.84 | (0.86–3.94) | 0.117 | |
| Ibadan, Nigeria | 0.88 | (0.52–1.13) | 0.549 | 1.48 | (0.74–2.94) | 0.263 | 1.07 | (0.52–2.22) | 0.847 | |
| Lagos, Nigeria | 0.55 | (0.25–1.19) | 0.127 | 0.93 | (0.36–2.45) | 0.888 | 0.81 | (0.30–2.24) | 0.691 | |
| Amputation | Age (Years) | 1.03 | (0.99–1.06) | 0.118 | 1.02 | (0.98–1.06) | 0.368 | 1.02 | (0.98–1.06) | 0.282 |
| Sex (Ref = males) | 0.57 | (0.28–1.17) | 0.124 | 0.62 | (0.28–1.37) | 0.239 | 0.65 | (0.29–1.46) | 0.298 | |
| BMI (Kg/m2) | 0.96 | (0.89–1.03) | 0.230 | 0.97 | (0.89–1.05) | 0.391 | 0.98 | (0.90–1.06) | 0.548 | |
| Duration of T2D | 1.08 | (1.04–1.12) | <0.001 | 1.07 | (1.02–1.12) | 0.003 | 1.07 | (1.03–1.12) | 0.002 | |
| Accra, Ghana | 2.07 | (0.94–4.55) | 0.070 | 1.31 | (0.46–3.76) | 0.611 | 1.37 | (0.47–3.97) | 0.565 | |
| Kumasi, Ghana | 0.93 | (0.28–3.09) | 0.907 | 0.73 | (0.18–2.96) | 0.663 | 1.01 | (0.25–4.16) | 0.984 | |
| Enugu, Nigeria | 0.94 | (0.32–2.70) | 0.903 | 0.65 | (0.19–2.25) | 0.492 | 0.70 | (0.20–2.45) | 0.574 | |
| Ibadan, Nigeria | 0.85 | (0.25–1.37) | 0.729 | 0.37 | (0.12–1.12) | 0.077 | 0.34 | (0.11–1.10) | 0.072 | |
| Lagos, Nigeriad | ||||||||||
| Stocking/glove numbness | Age (Years) | 1.02 | (1.01–1.02) | <0.001 | 1.02 | (1.01–1.02) | <0.001 | 1.02 | (1.01–1.03) | <0.001 |
| Sex (Ref = males) | 1.17 | (1.00–1.37) | 0.047 | 1.21 | (1.02–1.44) | 0.03 | 1.26 | (1.05–1.50) | 0.012 | |
| BMI (Kg/m2) | 0.98 | (0.96–0.99) | 0.001 | 0.99 | (0.97–1.00) | 0.126 | 0.99 | (0.97–1.00) | 0.100 | |
| Duration of T2D | 1.03 | (1.02–1.04) | <0.001 | 1.03 | (1.02–1.04) | <0.001 | 1.02 | (1.01–1.04) | <0.001 | |
| Accra, Ghana | 0.76 | (0.62–0.93) | 0.008 | 0.89 | (0.67–1.17) | 0.402 | 0.90 | (0.67–1.19) | 0.446 | |
| Kumasi, Ghana | 2.75 | (2.11–3.59) | <0.001 | 2.80 | (2.02–3.89) | <0.001 | 2.91 | (2.03–4.19) | <0.001 | |
| Enugu, Nigeria | 1.91 | (1.52–2.39) | <0.001 | 1.91 | (1.43–2.56) | <0.001 | 1.88 | (1.40–2.53) | <0.001 | |
| Ibadan, Nigeria | 0.96 | (0.63–0.87) | 0.669 | 0.86 | (0.67–1.09) | 0.210 | 0.77 | (0.60–0.98) | 0.035 | |
| Lagos, Nigeria | 0.50 | (0.38–0.67) | <0.001 | 0.59 | (0.42–0.83) | 0.003 | 0.60 | (0.43–0.86) | 0.005 | |
| TIA/Stroke | Age (Years) | 1.03 | (1.01–1.06) | 0.003 | 1.04 | (1.02–1.07) | 0.001 | 1.04 | (1.01–1.07) | 0.003 |
| Sex (Ref = males) | 1.14 | (0.70–1.86) | 0.592 | 1.10 | (0.65–1.88) | 0.721 | 1.10 | (0.62–1.96) | 0.747 | |
| BMI (Kg/m2) | 0.99 | (0.95–1.04) | 0.711 | 0.99 | (0.94–1.04) | 0.742 | 0.99 | (0.93–1.04) | 0.627 | |
| Duration of T2D | 1.00 | (0.97–1.04) | 0.961 | 0.99 | (0.95–1.03) | 0.512 | 0.99 | (0.95–1.03) | 0.709 | |
| Accra, Ghana | 1.32 | (0.76–2.31) | 0.325 | 5.68 | (1.62–19.91) | 0.007 | 5.71 | (1.62–20.10) | 0.007 | |
| Kumasi, Ghana | 1.89 | (1.04–3.43) | 0.038 | 7.89 | (2.22–28.06) | 0.001 | 6.94 | (1.83–26.32) | 0.004 | |
| Enugu, Nigeria | 1.61 | (0.91–2.85) | 0.099 | 6.16 | (1.76–21.53) | 0.004 | 6.24 | (1.78–21.84) | 0.004 | |
| Ibadan, Nigeria | 0.79 | (0.44–1.41) | 0.425 | 3.23 | (0.93–11.26) | 0.066 | 2.37 | (0.65–8.72) | 0.193 | |
| Lagos, Nigeria | 0.67 | (0.27–1.69) | 0.400 | 3.15 | (0.74–13.34) | 0.12 | 2.53 | (0.56–11.48) | 0.229 | |
| Erectile dysfunctione | Age (Years) | 1.02 | (1.00–1.03) | 0.007 | 1.02 | (1.00–1.03) | 0.007 | 1.02 | (1.01–1.04) | 0.001 |
| BMI (Kg/m2) | 0.98 | (0.95–1.01) | 0.186 | 0.99 | (0.96–1.03) | 0.647 | 1.00 | (0.97–1.04) | 0.804 | |
| Duration of T2D | 1.05 | (1.03–1.07) | <0.001 | 1.05 | (1.03–1.07) | <0.001 | 1.04 | (1.02–1.07) | <0.001 | |
| Accra, Ghana | 0.98 | (0.67–1.44) | 0.906 | 1.10 | (0.68–1.78) | 0.709 | 1.03 | (0.63–1.68) | 0.904 | |
| Kumasi, Ghana | 3.38 | (2.08–5.49) | 0.000 | 3.62 | (2.02–6.48) | <0.001 | 3.52 | (1.88–6.57) | <0.001 | |
| Enugu, Nigeria | 1.33 | (0.94–1.88) | 0.106 | 1.30 | (0.83–2.04) | 0.243 | 1.27 | (0.81–1.99) | 0.306 | |
| Ibadan, Nigeria | 0.61 | (0.33–0.58) | 0.001 | 0.51 | (0.34–0.77) | 0.001 | 0.39 | (0.25–0.60) | <0.001 | |
| Lagos, Nigeria | 1.59 | (1.08–2.35) | 0.020 | 1.62 | (0.99–2.64) | 0.055 | 1.54 | (0.93–2.55) | 0.095 |
uOR, unadjusted odds ratio from logistic regression model.
aOR, adjusted odds ratio from logistic regression model including all variables listed.
aOR, adjusted odds ratio from logistic regression model including all variables listed, plus glucose control (yes/no).
No amputations reported.
Men only. The reference site is Eldoret (Kenya).